Margaux Mignolet

Margaux Mignolet is a researcher at the University of Namur's URPHYM Namur Research Institute for Life Sciences. Her work focuses on understanding neurological post-acute sequelae of COVID-19 (PASC) through projects like the identification of pathogenic autoantibodies and development of 3D-brain organoids in SARS-CoV-2 infection contexts.

Research Trends: Her 2023 publication demonstrates that viral entry inhibitors can mitigate neurite shortening in neuronal cell models infected with SARS-CoV-2, suggesting potential therapeutic avenues for neurological manifestations of the virus. This aligns with her broader work on viral-host interactions and neuroimmunological consequences of infections.

Collaborations: She collaborates with Prof. Nicolas Gillet and Prof. Caroline Nicaise, with active projects spanning 2023-2026 investigating autoantibody mechanisms and neuronal neoantigen production.